Back to Journals » Cancer Management and Research » Volume 14

Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland

Total article views   HTML views PDF downloads Totals
7,106 Dovepress* 6,787+ 328 7,115
PubMed Central* 319 120 439
Totals 7,106 448 7,554
*Since 6 March 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar